Ruth Tomeno

Equibles does not estimate personal net worth.

About Ruth Tomeno

Ruth Tomeno has spoken on 1 investor event across 1 company, most recently for ELI LILLY & Co on June 6, 2026. ELI LILLY & Co is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at ELI LILLY & Co includes Juan Luciano (CEO), David Ricks (Chairman and Board Member), Kimberly Johnson (COO) and 6 others.

Ruth Tomeno on recent calls

“It's a real pleasure to tell you a little bit about alloralintide. This is a very unique molecule. It's a selective amylin receptor agonist. And when we made this molecule, we chose to emphasize selectivity for the amylin-1 receptor as opposed to other molecules, which emphasize amylin-3 receptor selectivity.”

Other, Lilly Investor Event at American Diabetes Association's (ADA) 86th Scientific Sessions · June 6, 2026